BioLineRx (BLRX) Tops Q2 EPS by 14c
Tweet
Share
E-mailBioLineRx (NASDAQ: BLRX) reported Q2 EPS of $0.00, $0.14 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $5.39 million versus the consensus estimate of $2.94 million.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
